This digital document is an article from Internal Medicine News, published by Thomson Gale on February 15, 2006. The length of the article is 1259 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: FDA panel endorses OTC approval of orlistat: the weight loss drug's potential for interactions with cyclosporine and warfarin prompted concern.
Author: Elizabeth Mechcatie
Publication:Internal Medicine News (Magazine/Journal)
Date: February 15, 2006
Publisher: Thomson Gale
Volume: 39 Issue: 4 Page: 29(1)
Distributed by Thomson Gale
FDA panel endorses OTC approval of orlistat: the weight loss drug's potential for interactions with cyclosporine and warfarin prompted concern.: An article from: Internal Medicine News
📄 Viewing lite version
Full site ›
⌛ 🇫🇷 France pricing being fetched…
Prices will appear once fetched — usually within a few minutes.
View in:
🇺🇸 USA
Book Details
Author(s)Elizabeth Mechcatie
PublisherThomson Gale
ISBN / ASINB000F0UXCK
ISBN-13978B000F0UXC2
MarketplaceFrance 🇫🇷